Abstract 437P
Background
Physician burnout negatively affects patient care, incurs added costs, and compromises the physician’s own safety. In the field of Medical Oncology, the demands entailed in caring for cancer patients combined with broader pressures on the healthcare system may present significant challenges for both physicians and nurses, including the risk for burnout. This study aims to determine the prevalence of burnout among Medical Oncology fellows-in-training in the Philippines, as well as identify which of the domains of burnout are commonly experienced by the fellows-in-training.
Methods
This is a descriptive cross-sectional study evaluating the prevalence of burnout among Medical Oncology fellows-in-training using the Maslach Burnout Inventory (MBI).
Results
Out of 70 Medical Oncology fellows-in-training, 50 participated in the survey. Most of the fellows-in-training were experiencing some degree of burnout during the conduct of the study. Fifty four percent (27) felt a high level of emotional exhaustion, while 38% (19) and 42% (21) felt a moderate level of burnout in the depersonalization and personal accomplishment domains respectively. Overall, 94% of respondents had a moderate to high level of burnout.
Conclusions
Physician burnout remains to be a considerable problem among Medical Oncology fellows-in-training in the Philippines. Majority of respondents experienced a moderate to high level of burnout, most commonly in the emotional exhaustion domain. Vacation leaves, recreational and wellness activities, and decreased work hours are some of the interventions cited to help reduce physician burnout.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
409P - Tertiary lymphoid structures are scarce but associated with BCR clonal expansion, B cell activity and checkpoint inhibitor response in advanced osteosarcoma
Presenter: Qiyuan Bao
Session: Poster viewing 06
410P - The incidence and risk factors of kidney injury in patients receiving immune checkpoint inhibitors: A retrospective observational cohort study
Presenter: Thanawat Suksomboon
Session: Poster viewing 06
411P - Cost-effective analysis of the various cancer screening methods in the community: Pooled analysis of camps of 5 years from 2017-to 2022
Presenter: Suresh Attili
Session: Poster viewing 06
412P - Substance-P in the blood is related with the efficacy of aprepitant for targeted drug-induced refractory pruritus in Chinese malignancy population
Presenter: Fang Gao
Session: Poster viewing 06
413P - Association of concomitant medications on survival outcomes in cancer patients treated with immune checkpoint inhibitors: Analysis of health insurance review and assessment database
Presenter: Soojung Hong
Session: Poster viewing 06
414P - Lessons learnt from clinico-genomic profiling of families with Li Fraumeni Syndrome: The largest case series from the Indian setting
Presenter: Ghazal Tansir
Session: Poster viewing 06
415P - Small cell lung cancer: Epidemiological patterns and mutational profile in the United States
Presenter: Abdallah Allam
Session: Poster viewing 06
416P - Survival outcomes predicted by irAEs on 18F-FDG-PET in response to PD-1 antibody therapy in metastatic melanoma
Presenter: Sarah Lewis
Session: Poster viewing 06
417P - The activity and safety of anlotinib for patients with recurrent malignant glioma: A single-center, retrospective study
Presenter: Xudong Sun
Session: Poster viewing 06
418P - Mutational landscape of non-small cell lung cancer in the United States
Presenter: Mostafa Elsayed
Session: Poster viewing 06